Heartbeat: Shaun Johns up for top imaging accolade

September 14, 2021

Getting nominated for a top accolade via one of the most highly respected bodies within your industry is quite an achievement. Well, Shaun Johns, a clinical scientist, knows a thing or two about exactly that as he was recently nominated for the Young Investigator’s Award by the British Nuclear Medicine Society.

Shaun explained: “As a trainee undertaking the scientist training programme, I am required to undertake and complete a Master’s project. I ordinarily work behind the scenes in the cleanroom, manufacturing radiopharmaceuticals for imaging. I had an interest in radioiodine therapy and was keen to work more closely with patients. After discussions with our heads of departments, we noted that the radioiodine therapy service had never received a formal service evaluation; and this became the focus of my project.”

The service evaluation took place over 12 months and assessed the clinical outcome and patient experience. Shaun continued: “I retrospectively assessed 300 patient follow up appointments to calculate the relative likelihood of failing treatment, as well as the likelihood of becoming euthyroid or hypothyroid. I also determined some useful links between disease type and the likelihood of the outcome.

“I used patient questionnaires to assess the experience of our patients. It included their full pathway before, during and after treatment. Through this questionnaire, I highlighted different ways to improve the patient’s experience and reduce pre-treatment anxiety. For example, clearer instructions and more detailed information about side-effects and what will happen on the day.

“As a result, I am unifying patient information for better clarity. I have rewritten patient information leaflets to include more detailed information.

I have included details about the likely outcome of their treatment and what they need to do after treatment. I am also looking to introduce a system whereby patients call us ahead of their therapy to discuss any special measures they may require. The aim is to improve patient awareness, improve compliance, reduce anxiety and maximise patient satisfaction.”

So what does Shaun think about being a finalist in the Young Investigator’s Award by the British Nuclear Medicine Society? “It was unexpected but very welcome. I didn’t take the award home, but being recognised for something you are passionate about is rewarding. It has encouraged me to continue to develop in this area.”

Jilly Croasdale, Head of Radiopharmacy Services, remarked: “Shaun has worked incredibly hard on this project and deserves all the recognition he receives. The work he has done has directly impacted upon and improved the patient experience. It is something Shaun should be incredibly proud of – we certainly are.”